Evidence map›Paper›PMID 23178490›Full record

ArticleOncogene2013

Tip60 degradation by adenovirus relieves transcriptional repression of viral transcriptional activator EIA.

A Gupta, S Jha, D A Engel, D A Ornelles, A Dutta

Abstract read
In one paragraph

Article in Oncogene, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 58 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

A GuptaDepartment of Biochemistry and Molecular Genetics, University of Virginia, School of Medicine, Charlottesville, VA, USA.
S Jha
D A Engel
D A Ornelles
A Dutta
University of Virginia · USWake Forest University · US

Funding

Regulation of TIP60 by the ubiquitin-proteasome pathwayR01GM084465 · NIGMS · UNIVERSITY OF VIRGINIA · PI DUTTA, ANINDYA · 2008 to 2017
$2.4M
NIGMS NIH HHS R01 GM084465
6 · The paper itself

Abstract

Adenoviruses are linear double-stranded DNA viruses that infect human and rodent cell lines, occasionally transform them and cause tumors in animal models. The host cell challenges the virus in multifaceted ways to restrain viral gene expression and DNA replication, and sometimes even eliminates the infected cells by programmed cell death. To combat these challenges, adenoviruses abrogate the cellular DNA damage response pathway. Tip60 is a lysine acetyltransferase that acetylates histones and other proteins to regulate gene expression, DNA damage response, apoptosis and cell cycle regulation. Tip60 is a bona fide tumor suppressor as mice that are haploid for Tip60 are predisposed to tumors. We have discovered that Tip60 is degraded by adenovirus oncoproteins EIB55K and E4orf6 by a proteasome-mediated pathway. Tip60 binds to the immediate early adenovirus promoter and suppresses adenovirus EIA gene expression, which is a master regulator of adenovirus transcription, at least partly through retention of the virally encoded repressor pVII on this promoter. Thus, degradation of Tip60 by the adenoviral early proteins is important for efficient viral early gene transcription and for changes in expression of cellular genes.

Indexed as

Adenovirus E1A ProteinsAdenovirus E4 ProteinsCell LineDNA, ViralEpithelial CellsGene Expression Regulation, ViralGene Knockdown TechniquesHCT116 CellsHistone AcetyltransferasesHumansLeupeptinsLysine Acetyltransferase 5Promoter Regions, GeneticProteasome InhibitorsAdenovirus E1A ProteinsAdenovirus E4 Proteinsbenzyloxycarbonylleucyl-leucyl-leucine aldehydeDNA, ViralE4orf6 protein, adenovirusHistone AcetyltransferasesKAT5 protein, humanLeupeptinsLysine Acetyltransferase 5Proteasome Inhibitors

Identifiers

PMID23178490
PMCPMC3955737
OpenAlexW1999771675

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.